Opinion

Most Recent

Sexual Politics and Science: Two Predicaments

By | April 1, 2009

A Matter of Conscience Editor's Note (March 31). The April issue of The Scientist includes an Opinion entitled "A Matter of Conscience" in which Alexander McPherson laid out his objections to sexual harassment training at the University of California at Irvine. In the meantime McPherson has participated in the training, for reasons given in the update below. The Opinion article follows the update. My conflict with the University of Califo

10 Comments

The Economic Stimulus and Science

By | March 1, 2009

A fixed percentage of a country's GDP should be committed to research.

6 Comments

Time for an IP Share Market?

By | February 1, 2009

Direct investment in market-valued intellectual property could drive translational success.

3 Comments

Tackling Human Resources in Africa

By | January 1, 2009

How one institute leverages overseas talent to develop its research strategy.

0 Comments

Disease Prevention in Islamic Countries

By | November 1, 2008

A network of international experts is setting up a Supercourse to meet the challenge.

2 Comments

What Makes Science 'Science'?

By | October 1, 2008

Trainee teachers don't have a clue, and most scientists probably don't either. That's bad news.

34 Comments

Foundation-led Drug Discovery

By | September 1, 2008

Virtual biotechs target and develop translational research.

0 Comments

A Head Start

By | August 1, 2008

How an undergraduate internship helped a student from the projects explore his love of science.

2 Comments

More Women at the Top

By | August 1, 2008

One program's success in preparing and sustaining women for leadership in the sciences.

2 Comments

Mobilizing Students for Change

By | July 1, 2008

An organization focused on neglected diseases links trainees North and South.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech